ochratoxin a has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bule, M; Khan, F; Niaz, K; Shah, SZA | 1 |
| Alvarez-Erviti, L; Arce-López, B; De Santis, B; Debegnach, F; González-Peñas, E; Izco, M; Lizarraga, E; López de Cerain, A; López-Calvo, S; Marzo-Sola, ME; Vettorazzi, A | 1 |
1 review(s) available for ochratoxin a and Alzheimer Disease
| Article | Year |
|---|---|
Ochratoxin A-induced genotoxic and epigenetic mechanisms lead to Alzheimer disease: its modulation with strategies.
Topics: Alzheimer Disease; DNA Damage; Epigenesis, Genetic; Female; Humans; Male; Ochratoxins | 2020 |
1 other study(ies) available for ochratoxin a and Alzheimer Disease
| Article | Year |
|---|---|
Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer's and Parkinson's Disease.
Topics: Alzheimer Disease; Biological Monitoring; Chromatography, Liquid; Humans; Mycotoxins; Neurodegenerative Diseases; Ochratoxins; Parkinson Disease; Sterigmatocystin; Tandem Mass Spectrometry; Trichothecenes; Zearalenone | 2021 |